Zkusit zdarma
Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.

CRL
Cena:
$ 160.30
+1.44 (0.91%)
Valuace
70
Růst
0
Zdraví
66
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?

Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?

10:40 20-05-2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t...

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

9:00 13-05-2026

Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategi...

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

8:00 13-05-2026

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories (CRL) and MEDIPOST Co....

Charles River Laboratories International Inc (CRL) Stock Down 5.2% -- Now Undervalued? GF Score: 79/100

Charles River Laboratories International Inc (CRL) Stock Down 5.2% -- Now Undervalued? GF Score: 79/100

1:23 12-05-2026

On May 12, 2026, Charles River Laboratories International Inc (CRL) shares fell 5.2%, bringing the c...

Charles River (CRL) Reliance on International Sales: What Investors Need to Know

Charles River (CRL) Reliance on International Sales: What Investors Need to Know

10:16 11-05-2026

Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's ...

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

8:00 11-05-2026

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (N...

Charles River Laboratories International Q1 Earnings Call Highlights

Charles River Laboratories International Q1 Earnings Call Highlights

19:05 09-05-2026

Charles River Laboratories International NYSE: CRL reported first-quarter 2026 results that manageme...

LH vs. CRL: Which Stock Is the Better Value Option?

LH vs. CRL: Which Stock Is the Better Value Option?

12:41 08-05-2026

Investors interested in stocks from the Medical Services sector have probably already heard of Labco...

These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results

These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results

11:11 08-05-2026

Charles River Laboratories (NYSE: CRL) beat Q1 earnings estimates but lowered its FY2026 forecast. A...

Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript

Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript

15:21 07-05-2026

Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript...

Charles River Q1 Review: Near-Term Stability But Long-Term Risks (Downgrade)

Charles River Q1 Review: Near-Term Stability But Long-Term Risks (Downgrade)

12:26 07-05-2026

Charles River Laboratories is downgraded to 'Sell' as shares have rallied 57% in the past year, outp...

CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down

CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down

11:20 07-05-2026

Charles River beats Q1 earnings and revenue estimates, but margin declines and weak organic growth i...

Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics

Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics

10:31 07-05-2026

The headline numbers for Charles River (CRL) give insight into how the company performed in the quar...

Charles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue Estimates

Charles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue Estimates

9:56 07-05-2026

Charles River Laboratories (CRL) came out with quarterly earnings of $2.06 per share, beating the Za...

Charles River beats quarterly estimates on steady demand for drug development services

Charles River beats quarterly estimates on steady demand for drug development services

7:54 07-05-2026

Contract drug developer Charles River Laboratories on Thursday beat Wall Street expectations for fir...

Charles River Laboratories Announces First-Quarter 2026 Results

Charles River Laboratories Announces First-Quarter 2026 Results

7:00 07-05-2026

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces First-Quarter 2026 Financia...

Charles River (CRL) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Charles River (CRL) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

10:15 06-05-2026

Evaluate the expected performance of Charles River (CRL) for the quarter ended March 2026, looking b...

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

11:06 30-04-2026

Charles River (CRL) possesses the right combination of the two key ingredients for a likely earnings...

Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities

Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities

8:00 30-04-2026

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories today announced an enh...

Here's Why Charles River Laboratories (CRL) is a Strong Value Stock

Here's Why Charles River Laboratories (CRL) is a Strong Value Stock

10:45 28-04-2026

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the ...

close

HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

12-02-2026
SHAREHOLDERS SHOULD CONTACT THE FIRM IMMEDIATELY AS THERE MAY BE LIMITED TIME TO ENFORCE YOUR RIGHTS...
Více zde

CHARLES RIVER LABORATORIES SCHEDULES FOURTH-QUARTER 2025 EARNINGS AND 2026 GUIDANCE RELEASE AND CONFERENCE CALL

21-01-2026
WILMINGTON, MASS.--(BUSINESS WIRE)--CHARLES RIVER LABORATORIES SCHEDULES FOURTH-QUARTER 2025 EARNING...
Více zde

CHARLES RIVER ENTERS MANUFACTURING COLLABORATION WITH GAZI UNIVERSITY

21-01-2026
WILMINGTON, MASS.--(BUSINESS WIRE)---- $CRL #CDMO--CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (N...
Více zde

CHARLES RIVER LABORATORIES INVESTIGATION INITIATED: KAHN SWICK & FOTI, LLC INVESTIGATES THE OFFICERS AND DIRECTORS OF CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - CRL

20-01-2026
NEW YORK AND NEW ORLEANS, JAN. 20, 2026 /PRNEWSWIRE/ -- FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLE...
Více zde

CHARLES RIVER LABORATORIES PROVIDES BUSINESS UPDATES

12-01-2026
WILMINGTON, MASS.--(BUSINESS WIRE)--CHARLES RIVER LABORATORIES PROVIDES BUSINESS UPDATES....
Více zde

CHARLES RIVER LABORATORIES ANNOUNCES PLANNED RETIREMENT OF JAMES C. FOSTER AND CEO SUCCESSION PLAN

08-01-2026
WILMINGTON, MASS.--(BUSINESS WIRE)--CHARLES RIVER LABORATORIES ANNOUNCES PLANNED RETIREMENT OF JAMES...
Více zde

TELIX (TLX) 2-DAY DEADLINE ALERT: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

07-01-2026
SAN FRANCISCO, JAN. 07, 2026 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN ...
Více zde

TELIX (TLX) 4-DAY DEADLINE ALERT: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

05-01-2026
SAN FRANCISCO, JAN. 05, 2026 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN...
Více zde

TLX 5-DAY DEADLINE ALERT: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

04-01-2026
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

TLX 6-DAY DEADLINE ALERT: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

03-01-2026
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

TLX 7-DAY DEADLINE ALERT: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

02-01-2026
SAN FRANCISCO, JAN. 02, 2026 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

01-01-2026
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

TLX CLASS ACTION DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

31-12-2025
SAN FRANCISCO, DEC. 31, 2025 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN...
Více zde

TLX 11-DAY DEADLINE ALERT: HAGENS BERMAN URGES TELIX (TLX) INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

29-12-2025
SAN FRANCISCO, DEC. 29, 2025 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

27-12-2025
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

TLX CLASS ACTION DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

25-12-2025
SAN FRANCISCO, DEC. 25, 2025 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN ...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

24-12-2025
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

TLX LAWSUIT DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

23-12-2025
SAN FRANCISCO, DEC. 23, 2025 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

22-12-2025
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

TLX LAWSUIT DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

19-12-2025
PARTNER REED KATHREIN SCRUTINIZES ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND ...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

18-12-2025
SAN FRANCISCO, DEC. 18, 2025 (GLOBE NEWSWIRE) -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN...
Více zde

TLX LAWSUIT DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

17-12-2025
SAN FRANCISCO , DEC. 17, 2025 /PRNEWSWIRE/ -- NATIONAL SHAREHOLDER RIGHTS LAW FIRM HAGENS BERMAN IS ...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

15-12-2025
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

12-12-2025
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND...
Více zde

21% TLX PLUNGE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 IN CLASS ACTION SUIT OVER SEC SUBPOENA & FDA CRL ON MANUFACTURING FAILURES

11-12-2025
PARTNER REED KATHREIN SCRUTINIZING ALLEGED MISSTATEMENTS ON PROSTATE CANCERDRUG TLX591 PROGRESS AND ...
Více zde

CHARLES RIVER EXTENDS COMMITMENT TO ADVANCED THERAPY DEVELOPERS WITH SECOND INCUBATOR PROGRAM COHORT

11-12-2025
WILMINGTON, MASS.--(BUSINESS WIRE)---- $CRL #CDMO--CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (N...
Více zde

TLX LAWSUIT DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

09-12-2025
PARTNER REED KATHREIN SCRUTINIZES ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND ...
Více zde

TELIX (TLX) FACING SECURITIES CLASS ACTION LAWSUIT OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN – HAGENS BERMAN

08-12-2025
PARTNER REED KATHREIN SCRUTINIZES ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND ...
Více zde

TLX LAWSUIT DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

05-12-2025
PARTNER REED KATHREIN SCRUTINIZES ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND ...
Více zde

TLX LAWSUIT DEADLINE: HAGENS BERMAN URGES TELIX INVESTORS TO ACT BY JAN. 9 OVER ALLEGED DUAL REGULATORY FAILURES: SEC SUBPOENA & FDA CRL ON CMC/SUPPLY CHAIN

04-12-2025
PARTNER REED KATHREIN SCRUTINIZES ALLEGED MISSTATEMENTS ON PROSTATE CANCER DRUG TLX591 PROGRESS AND ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-13 00:00:008-KStáhnout
2026-01-09 00:00:008-KStáhnout
2025-12-03 00:00:008-KStáhnout
2025-11-17 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-09-16 01:00:008-KStáhnout
2025-09-16 00:00:008-KStáhnout
2025-08-06 01:00:008-KStáhnout
2025-08-06 01:00:0010-QStáhnout
2025-08-06 00:00:008-KStáhnout
2025-08-06 00:00:0010-QStáhnout
2025-05-23 01:00:008-KStáhnout
2025-05-23 00:00:008-KStáhnout
2025-05-07 01:00:008-KStáhnout
2025-05-07 01:00:0010-QStáhnout
2025-05-07 00:00:008-KStáhnout
2025-05-07 00:00:0010-QStáhnout
2025-02-21 00:00:008-KStáhnout
2025-02-20 23:00:008-KStáhnout
2025-02-19 00:00:008-KStáhnout
2025-02-19 00:00:0010-KStáhnout
2025-02-18 23:00:008-KStáhnout
2025-02-18 23:00:0010-KStáhnout
2025-01-14 00:00:008-KStáhnout
2025-01-13 23:00:008-KStáhnout
2024-12-13 00:00:008-KStáhnout
2024-12-12 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-05-10 01:00:008-KStáhnout
2024-05-10 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-02-14 00:00:008-KStáhnout
2024-02-14 00:00:0010-KStáhnout
2024-02-13 23:00:008-KStáhnout
2024-02-13 23:00:0010-KStáhnout
2024-01-24 00:00:008-KStáhnout
2024-01-23 23:00:008-KStáhnout
2024-01-16 00:00:008-KStáhnout
2024-01-15 23:00:008-KStáhnout
2023-11-15 00:00:008-KStáhnout
2023-11-14 23:00:008-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-08 00:00:0010-QStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-07 23:00:0010-QStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-02-22 00:00:008-KStáhnout
2023-02-22 00:00:0010-KStáhnout
2023-02-21 23:00:008-KStáhnout
2023-02-21 23:00:0010-KStáhnout
2022-12-06 00:00:008-KStáhnout
2022-12-05 23:00:008-KStáhnout
2022-11-30 00:00:008-KStáhnout
2022-11-29 23:00:008-KStáhnout
2022-11-02 00:00:008-KStáhnout
2022-11-02 00:00:0010-QStáhnout
2022-11-01 23:00:008-KStáhnout
2022-11-01 23:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 01:00:0010-QStáhnout
2022-08-03 00:00:008-KStáhnout
2022-08-03 00:00:0010-QStáhnout
2022-06-08 01:00:008-KStáhnout
2022-06-08 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-03-28 01:00:008-KStáhnout
2022-03-28 00:00:008-KStáhnout
2022-02-16 00:00:008-KStáhnout
2022-02-16 00:00:0010-KStáhnout
2022-02-15 23:00:008-KStáhnout
2022-02-15 23:00:0010-KStáhnout
2022-01-11 00:00:008-KStáhnout
2022-01-10 23:00:008-KStáhnout
2021-12-27 00:00:008-KStáhnout
2021-12-26 23:00:008-KStáhnout
2021-12-15 00:00:008-KStáhnout
2021-12-14 23:00:008-KStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-11 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-03 00:00:0010-QStáhnout
2021-11-02 23:00:008-KStáhnout
2021-11-02 23:00:0010-QStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 01:00:0010-QStáhnout
2021-08-04 00:00:008-KStáhnout
2021-08-04 00:00:0010-QStáhnout
2021-05-18 01:00:008-KStáhnout
2021-05-18 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 01:00:0010-QStáhnout
2021-05-04 00:00:008-KStáhnout
2021-05-04 00:00:0010-QStáhnout
2021-04-23 01:00:008-KStáhnout
2021-04-23 00:00:008-KStáhnout
2021-03-29 01:00:008-KStáhnout
2021-03-29 00:00:008-KStáhnout
2021-03-23 00:00:008-KStáhnout
2021-03-22 23:00:008-KStáhnout
2021-03-09 00:00:008-KStáhnout
2021-03-08 23:00:008-KStáhnout
2021-02-17 00:00:008-KStáhnout
2021-02-17 00:00:0010-KStáhnout
2021-02-16 23:00:008-KStáhnout
2021-02-16 23:00:0010-KStáhnout
2020-10-29 00:00:008-KStáhnout
2020-10-29 00:00:0010-QStáhnout
2020-10-28 23:00:008-KStáhnout
2020-10-28 23:00:0010-QStáhnout
2020-10-19 01:00:008-KStáhnout
2020-10-19 00:00:008-KStáhnout
2020-08-05 01:00:008-KStáhnout
2020-08-05 01:00:0010-QStáhnout
2020-08-05 00:00:008-KStáhnout
2020-08-05 00:00:0010-QStáhnout
2020-05-08 01:00:008-KStáhnout
2020-05-08 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-03-04 00:00:008-KStáhnout
2020-03-03 23:00:008-KStáhnout
2020-02-11 00:00:008-KStáhnout
2020-02-11 00:00:0010-KStáhnout
2020-02-10 23:00:008-KStáhnout
2020-02-10 23:00:0010-KStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-06 00:00:0010-QStáhnout
2019-11-05 23:00:008-KStáhnout
2019-11-05 23:00:0010-QStáhnout
2019-10-23 01:00:008-KStáhnout
2019-10-23 00:00:008-KStáhnout
2019-10-21 01:00:008-KStáhnout
2019-10-21 00:00:008-KStáhnout
2019-10-01 01:00:008-KStáhnout
2019-10-01 00:00:008-KStáhnout
2019-08-02 01:00:008-KStáhnout
2019-08-02 00:00:008-KStáhnout
2019-07-31 01:00:008-KStáhnout
2019-07-31 01:00:0010-QStáhnout
2019-07-31 00:00:008-KStáhnout
2019-07-31 00:00:0010-QStáhnout
2019-05-22 01:00:008-KStáhnout
2019-05-22 00:00:008-KStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:008-KStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-05-01 01:00:008-KStáhnout
2019-05-01 00:00:008-KStáhnout
2019-04-30 01:00:008-KStáhnout
2019-04-30 00:00:008-KStáhnout
2019-02-15 00:00:008-KStáhnout
2019-02-14 23:00:008-KStáhnout
2019-02-13 00:00:008-KStáhnout
2019-02-13 00:00:0010-KStáhnout
2019-02-12 23:00:008-KStáhnout
2019-02-12 23:00:0010-KStáhnout
2018-11-07 00:00:008-KStáhnout
2018-11-07 00:00:0010-QStáhnout
2018-11-06 23:00:008-KStáhnout
2018-11-06 23:00:0010-QStáhnout
2018-10-03 01:00:008-KStáhnout
2018-10-03 00:00:008-KStáhnout
2018-08-31 01:00:008-KStáhnout
2018-08-31 00:00:008-KStáhnout
2018-08-08 01:00:008-KStáhnout
2018-08-08 01:00:0010-QStáhnout
2018-08-08 00:00:008-KStáhnout
2018-08-08 00:00:0010-QStáhnout
2018-06-14 01:00:008-KStáhnout
2018-06-14 00:00:008-KStáhnout
2018-05-14 01:00:008-KStáhnout
2018-05-14 00:00:008-KStáhnout
2018-05-10 01:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:008-KStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-04-03 01:00:008-KStáhnout
2018-04-03 00:00:008-KStáhnout
2018-03-26 01:00:008-KStáhnout
2018-03-26 00:00:008-KStáhnout
2018-02-13 00:00:008-KStáhnout
2018-02-13 00:00:0010-KStáhnout
2018-02-12 23:00:008-KStáhnout
2018-02-12 23:00:0010-KStáhnout
2018-01-16 00:00:008-KStáhnout
2018-01-15 23:00:008-KStáhnout
2018-01-09 00:00:008-KStáhnout
2018-01-08 23:00:008-KStáhnout
2017-11-24 00:00:008-KStáhnout
2017-11-23 23:00:008-KStáhnout
2017-11-09 00:00:008-KStáhnout
2017-11-09 00:00:0010-QStáhnout
2017-11-08 23:00:008-KStáhnout
2017-11-08 23:00:0010-QStáhnout
2017-08-09 01:00:008-KStáhnout
2017-08-09 01:00:0010-QStáhnout
2017-08-09 00:00:008-KStáhnout
2017-08-09 00:00:0010-QStáhnout
2017-07-06 01:00:008-KStáhnout
2017-07-06 00:00:008-KStáhnout
2017-05-11 01:00:008-KStáhnout
2017-05-11 00:00:008-KStáhnout
2017-05-10 01:00:008-KStáhnout
2017-05-10 01:00:0010-QStáhnout
2017-05-10 00:00:008-KStáhnout
2017-05-10 00:00:0010-QStáhnout
2017-04-26 01:00:008-KStáhnout
2017-04-26 00:00:008-KStáhnout
2017-02-14 00:00:008-KStáhnout
2017-02-14 00:00:0010-KStáhnout
2017-02-13 23:00:008-KStáhnout
2017-02-13 23:00:0010-KStáhnout
2017-01-10 00:00:008-KStáhnout
2017-01-09 23:00:008-KStáhnout
2016-11-02 00:00:008-KStáhnout
2016-11-02 00:00:0010-QStáhnout
2016-11-01 23:00:008-KStáhnout
2016-11-01 23:00:0010-QStáhnout
2016-08-03 01:00:008-KStáhnout
2016-08-03 01:00:0010-QStáhnout
2016-08-03 00:00:008-KStáhnout
2016-08-03 00:00:0010-QStáhnout
2016-05-16 01:00:008-KStáhnout
2016-05-16 00:00:008-KStáhnout
2016-05-04 01:00:008-KStáhnout
2016-05-04 01:00:0010-QStáhnout
2016-05-04 00:00:008-KStáhnout
2016-05-04 00:00:0010-QStáhnout
2016-04-05 01:00:008-KStáhnout
2016-04-05 00:00:008-KStáhnout
2016-03-10 00:00:008-KStáhnout
2016-03-09 23:00:008-KStáhnout
2016-02-12 00:00:0010-KStáhnout
2016-02-11 23:00:0010-KStáhnout
2016-02-10 00:00:008-KStáhnout
2016-02-09 23:00:008-KStáhnout
2016-01-19 00:00:008-KStáhnout
2016-01-18 23:00:008-KStáhnout
2016-01-08 00:00:008-KStáhnout
2016-01-07 23:00:008-KStáhnout
2015-12-10 00:00:008-KStáhnout
2015-12-09 23:00:008-KStáhnout
2015-11-04 00:00:008-KStáhnout
2015-11-04 00:00:0010-QStáhnout
2015-11-03 23:00:008-KStáhnout
2015-11-03 23:00:0010-QStáhnout
2015-08-18 01:00:008-KStáhnout
2015-08-18 00:00:008-KStáhnout
2015-07-30 01:00:008-KStáhnout
2015-07-30 01:00:0010-QStáhnout
2015-07-30 00:00:008-KStáhnout
2015-07-30 00:00:0010-QStáhnout
2015-05-11 01:00:008-KStáhnout
2015-05-11 00:00:008-KStáhnout
2015-04-30 01:00:008-KStáhnout
2015-04-30 01:00:0010-QStáhnout
2015-04-30 00:00:008-KStáhnout
2015-04-30 00:00:0010-QStáhnout
2015-04-22 01:00:008-KStáhnout
2015-04-22 00:00:008-KStáhnout
2015-02-27 00:00:008-KStáhnout
2015-02-26 23:00:008-KStáhnout
2015-02-17 00:00:0010-KStáhnout
2015-02-16 23:00:0010-KStáhnout
2015-02-11 00:00:008-KStáhnout
2015-02-10 23:00:008-KStáhnout
2014-12-02 00:00:008-KStáhnout
2014-12-01 23:00:008-KStáhnout
2014-11-03 00:00:008-KStáhnout
2014-11-02 23:00:008-KStáhnout
2014-10-30 00:00:0010-QStáhnout
2014-10-29 23:00:0010-QStáhnout
2014-10-29 00:00:008-KStáhnout
2014-10-28 23:00:008-KStáhnout
2014-08-07 01:00:008-KStáhnout
2014-08-07 01:00:0010-QStáhnout
2014-08-07 00:00:008-KStáhnout
2014-08-07 00:00:0010-QStáhnout
2014-05-09 01:00:008-KStáhnout
2014-05-09 00:00:008-KStáhnout
2014-04-30 01:00:008-KStáhnout
2014-04-30 01:00:0010-QStáhnout
2014-04-30 00:00:0010-QStáhnout
2014-04-04 01:00:008-KStáhnout
2014-04-04 00:00:008-KStáhnout
2014-02-24 23:00:0010-KStáhnout
2014-02-11 23:00:008-KStáhnout
preloader